Categories

Two PQT Medicines trainings for regulators in 2022

14th Annual PQT Medicines Quality Assessment Training
14 – 17 June 2022 (Virtual)

1st Biotherapeutic Product (BTP) and Similar Biotherapeutic Product (SBP) assessment training
18 June 2022 (Virtual)

Two PQT Medicines trainings for regulators in 2022 | WHO – Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

 
Categories

Philips Respironics Issues Voluntary Recall Notification/Field Safety Notice* for the V60 Ventilator Product Family

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its subsidiary Philips Respironics is notifying customers of its V60/V60 Plus and V680 ventilators about a potential issue with the electrical circuit in these ventilators that controls the 35V power sup

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/philips-respironics-issues-voluntary-recall-notificationfield-safety-notice-v60-ventilator-product

 
Categories

Fagron Inc. Issues Voluntary Nationwide Recall of SyrSpend SF Cherry Due to Microbial Contamination

St. Paul, Minnesota, Fagron Inc. (“Fagron”) is voluntarily recalling two lots of SyrSpend SF Cherry to the hospital, pharmacy, and distributor level out of an abundance of caution. The affected lots are potentially contaminated with Burkholderia gladioli. Burkholderia gladioli is an opportunistic pa

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fagron-inc-issues-voluntary-nationwide-recall-syrspend-sf-cherry-due-microbial-contamination

 
Categories

Celltrion USA Recalls Certain Point of Care DiaTrust COVID-19 Ag Rapid Test Kits Which May Have Been Distributed to Unauthorized, Non-CLIA-Certified Users

COVID-19 Ag Rapid Tests are being recalled because they may have been distributed to unauthorized, non-CLIA-certified users.

http://www.fda.gov/medical-devices/medical-device-recalls/celltrion-usa-recalls-certain-point-care-diatrust-covid-19-ag-rapid-test-kits-which-may-have-been

 
Categories

Radiothérapie adjuvante pour le traitement du cancer du sein de stade précoce: efficacité et innocuité d’une irradiation complète du sein en 5 fractions (ultrahypofractionnement)

Radiothérapie adjuvante pour le traitement du cancer du sein de stade précoce: efficacité et innocuité d’une irradiation complète du sein en 5 fractions (ultrahypofractionnement)
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1367477